Skip to main content
×
Home
    • Aa
    • Aa

Zanamivir Use During Transmission of Amantadine-Resistant Influenza A in a Nursing Home

  • Christine Lee (a1), Mark Loeb (a2), Anne Phillips (a3), Judy Nesbitt (a4), Karen Smith (a4), Margaret Fearon (a5), Margaret A. McArthur (a1), Tony Mazzulli (a1), Yan Li (a6) and Allison McGeer (a1)...
Abstract
AbstractObjective:

To describe the use of zanamivir during an influenza A outbreak.

Population:

Residents of a 176-bed long-term-care facility for the elderly in Newmarket, Ontario, Canada, 90% of whom received influenza vaccine in the fall of 1998.

Outbreak:

When respiratory illness due to influenza A was confirmed, infection control measures and amantadine prophylaxis were initiated. Despite these measures, transmission of influenza A continued.

Intervention:

Zanamivir inhalations, 10 mg daily for prophylaxis and 10 mg twice daily for treatment of influenza.

Results:

There were 13 definite and 66 probable outbreak-associated cases of influenza A. Twelve (15%) cases developed pneumonia, 7 (9%) were hospitalized, and 2 (2.6%) died. All 12 culture-positive cases yielded influenza A/Sydney/H3N2/05/97-like virus, a 1998/99 vaccine component. The three isolates obtained prior to the initiation of amantadine were amantadine-susceptible; all nine obtained after prophylaxis was instituted were amantadine-resistant. One hundred twenty-nine (92%) of 140 residents who were offered zanamivir accepted it and were able to attempt inhalations. Of these 129, 78% (100) had no difficulty in complying with inhalations. Difficulty with inhalations was associated with decreased functional and mental status. Fifteen (58%) of 26 residents fully dependent in activities of daily living had difficulty compared to 14 (14%) of 100 others (P<.001). Twenty-two (45%) of 49 residents not oriented to person, place, or time had difficulty compared to 7 (10%) of 77 others (P<001). In the 2 weeks after zanamivir prophylaxis, only 2 new cases of respiratory illness occurred, neither confirmed as influenza. No side effects were identified in 128 zanamivir-treated residents.

Conclusion:

A minority of nursing home residents have difficulty following instructions for zanamivir inhalations. Zanamivir was well tolerated, and its use was temporally associated with termination of an outbreak that amantadine had failed to control.

Copyright
Corresponding author
Room 1460, Department of Microbiology, Mount Sinai Hospital, 600 University Ave, Toronto, Ontario M5G 1X5, Canada
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

6. WL Atkinson , NH Arden , PA Patriarca N Leslie , KJ Lui , R Gohd . Amantadine prophylaxis during an institutional outbreak of type A (H1N1) influenza. Arch Intern Med 1986;146:17511756.

8. J Degelau , SK Somani SL Cooper , DR Guay , KB Crossley . Amantadine-resistant influenza A in a nursing facility. Ardi Intern Med 1992;152:390392.

9. P Houck , M Hemphill , S LaCroix , D Hirsh , N Cox . Amantadine-resistant influenza A in a nursing homes. Identification of a resistant virus prior to drug use. Arch Intern Med 1995;155:533537.

10. FG Hayden , AD Osterhaus , JJ Treanor , DM Fleming , FY Aoki , KG Nicholson , et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. N Engl J Med 1997;337:874880.

12. AS Monto , DP Robinson , ML Herlocher , JM Hinson Jr, MJ Elliott , A Crisp Zanamivir in the prevention of influenza among healthy adults: a randomized controlled txial. JAMA 1999;282:3135.

13. M Schilling , L Povinelli , P Krause , M Gravenstein , Ambrozaitis A HH Jones , et al. Efficacy of zanamivir for chemoprophylaxis of nursing home outbreaks. Vaccine 1998;16:17711774.

14. A McGeer , B Campbell , TG Emori , WJ Hierholzer , MM Jackson , LE Nicolle , et al. Definitions of infection for surveillance in long-term care facilities. Am J Infect Control 1991;19:17.

15. S Katz , TD Downs , HR Cash , RD Frotz . Progress in the development of the index of ADL. Gerontologist 1970;10:2030.

18. PA Patriarca JA Weber RA Parker WN Hall , AP Kendal , DJ Bregman , et al. Efficacy of influenza vaccines in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA 1985;253:11361139.

20. J Potter , DJ Stott , MA Roberts AG Elder , B O'Donnell , PV Knight , et al. Influenza vaccination of health care workers in long-term-care hospitals reduces mortality of elderly patients. J Infect Dis 1997;175:16.

21. WF Carman , AG Elder , LA Wallace , K McAulay , Walker A GD Murray , et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet 2000;355:9397.

22. TM Goevart , CT Thijs , N Masurel , JJ Sprenger , GJ Dinant , JA Knottnerus The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 1994;272:16611665.

23. PA Gross AW Hermogenes , HS Sacks , J Lau , RA Levandowski The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995;123:518527.

24. MA Strassburg , S Greenland , FJ Sondilo , LE Lieb , LA Habel Influenza in the elderly: report of an outbreak and a review of vaccine effectiveness reports. Vaccine 1986;4:3844.

25. SE Ohmit , NH Arden , AS Monto . Effectiveness of inactivated influenza vaccine among nursing home residents during an influenza type A (H3N2) epidemic. J Am Geriatr Soc 1999;47:165–71.

27. R Dolin , RC Reichman , HP Madore , R Maynard , PN Linton , J Webber-Jones . A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med 1982;307:580584.

28. FG Hayden . Antivirals for pandemic influenza. J Infect Dis 1997;176(suppl 1):S56S61.

29. NH Arden , PA Patriarca , MB Fasano , KJ Lui , MW Harmon , AP Kendal , et al. The roles of vaccination and amantadine prophylaxis in controlling an outbreak of influenza A (H3N2) in a nursing home. Arch Intern Med 1988;148:865868.

30. NL Peters , S Oboler , C Hair , L Laxson , J Kost , G Meiklejohn . Treatment of an influenza A outbreak in a teaching nursing home. Effectiveness of a protocol for prevention and control. J Am Geriatr Soc 1989;37:210218.

32. HG Hayden , RB Belshe , RD Clover , AJ Hay , MJ Oakes , W Soo . Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. N Engl J Med 1989;321:16961702.

33. FG Hayden , RL Atmar , M Schilling , C Johnson , D Poretz , D Paar , et al. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med 1999;341:13361343.

35. LV Gubareva , L Kaiser , FG Hayden . Influenza virus neuraminidase inhibitors. Lancet 2000;355:827835.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Infection Control & Hospital Epidemiology
  • ISSN: 0899-823X
  • EISSN: 1559-6834
  • URL: /core/journals/infection-control-and-hospital-epidemiology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 1 *
Loading metrics...

Abstract views

Total abstract views: 150 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 23rd September 2017. This data will be updated every 24 hours.